256 Newsroom — Uganda's Digital News Infrastructure
Business

Bristol Myers ends deal with Cellares, cell therapy manufacturer to reorg - Endpoints News

Published by Endpoints.news By Anna Brown · 25 August 2026 at 15:00
Share
Bristol Myers ends deal with Cellares, cell therapy manufacturer to reorg - Endpoints News
Image · Endpoints.news

What the report says

Bristol Myers exits its Cellares CAR-T manufacturing deal after the Cell Shuttle falls short, prompting a reorg at Cellares.

Read the full report at Endpoints.news →

Loading debate for this article…

Other publishers covering this story

No additional verified coverage is currently clustered with this report.

More stories by this journalist

Other publications from this journalist — open any story without leaving the article page.

No other published stories from this publisher yet.

Related reporting

King Oyo buried as Omusuuga reaffirms new monarchThe Observer Thousands mourn King Oyo at funeral ceremony in Fort PortalThe Independent Uganda 256 Newsroom 256Shield gives institutions a practical way to see, test and manage cyber risk256Shield 256 Newsroom Busoga eyes coffee, cocoa tourism to create jobs - Daily MonitorDaily Monitor Ugandan farmers count heavy losses as drought withers crops, weakens livestockThe Independent Uganda Spiro Partners With Yadea to Scale Electric Mobility Across AfricaNile Post